Science Explorer Back to mapMap
Discussion
Researcher · University of Milan · Italy

RS Rosenson

RS Rosenson publishes mostly in Surgery, Cancer Research and Economics and Econometrics, on topics such as Lipoproteins and Cardiovascular Health, Cancer, Lipids, and Metabolism and Pharmaceutical Economics and Policy.

OpenAlex
World rank
#5,606,136
of 7,710,434 ranked researchers
Rank in Italy
#187,269
of 242,206
Works
18
Citations
5
Citations per work
0.3
h-index
1
i10-index 0Top 99.4% in Surgery
RS Rosenson

What does RS Rosenson research?

RS Rosenson's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (16%), Economics, Econometrics and Finance (11%).

Health Sciences: 8 works · 45.9% of their workMedicine: 8 works · 45.9% of their workSurgery: 7 works · 40.5% of their workCardiology and Cardiovascular Medicine: 1 works · 5.4% of their workEverything else: 4 works · 21.7% of their workLife Sciences: 4 works · 21.6% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 16.2% of their workCancer Research: 3 works · 16.2% of their workNeuroscience: 0 works · 2.7% of their workNeurology: 0 works · 2.7% of their workPharmacology, Toxicology and Pharmaceutics: 0 works · 2.7% of their workPharmacology: 0 works · 2.7% of their workSocial Sciences: 2 works · 10.8% of their workEconomics, Econometrics and Finance: 2 works · 10.8% of their workEconomics and Econometrics: 2 works · 10.8% of their workTHEIR WORKRS Rosenson18works
Life Sciences22%Health Sciences46%Social Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine845.9%
  2. Everything else421.7%
    1. Biochemistry, Genetics and Molecular Biology316.2%
    2. Neuroscience02.7%
    3. Pharmacology, Toxicology and Pharmaceutics02.7%
    1. Economics, Econometrics and Finance210.8%
  1. 1Surgery40% of their works
  2. 2Cancer Research16% of their works
  3. 3Economics and Econometrics11% of their works
  4. 4Cardiology and Cardiovascular Medicine5% of their works
  5. 5Pharmacology3% of their works
  6. 6Neurology3% of their works

Research topics

Which keywords describe RS Rosenson's research?

The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, Fatty Acid Synthase, Lipid Metabolism, Drug Development Costs, Generic Drugs and Chamber Quantification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Statins202 topics
  2. Cardiovascular Disease Prevention141 topic
  3. Cholesterol-lowering141 topic
  4. Fatty Acid Synthase61 topic
  5. Lipid Metabolism61 topic
  6. Drug Development Costs31 topic
  7. Generic Drugs31 topic
  8. Chamber Quantification21 topic
  9. Echocardiography21 topic
  10. Cerebrolysin11 topic
  11. Citicoline11 topic
  12. Electrochemical Biosensors11 topic
  13. Graphene11 topic
  14. Green Analytical Chemistry11 topic
  15. Icariin11 topic
  16. Pharmaceutical Analysis11 topic
  17. Pharmacological Effects11 topic

Where does RS Rosenson work?

RS Rosenson's main affiliation in the publication record is University of Milan, Italy.

How many publications and citations does RS Rosenson have?

OpenAlex counts 18 works and 5 citations for RS Rosenson, an h-index of 1, ranking #5,606,136 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about RS Rosenson. Posts are plain text and can be reported.